{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:04:19Z","timestamp":1793419459757,"version":"4.5.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AA015951"],"award-info":[{"award-number":["AA015951"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK44442"],"award-info":[{"award-number":["DK44442"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK58379"],"award-info":[{"award-number":["DK58379"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.mce.2022.111618","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T20:29:17Z","timestamp":1646944157000},"page":"111618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":299,"special_numbering":"C","title":["Discovery of farnesoid X receptor and its role in bile acid metabolism"],"prefix":"10.1016","volume":"548","author":[{"given":"John Y.L.","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-3330","authenticated-orcid":false,"given":"Jessica M.","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mce.2022.111618_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep4.1814","article-title":"What does the future hold for patients with nonalcoholic steatohepatitis: diagnostic strategies and treatment options in 2021 and beyond?","volume":"5","author":"Alkhouri","year":"2021","journal-title":"Hepatol Commun"},{"issue":"47","key":"10.1016\/j.mce.2022.111618_bib2","doi-asserted-by":"crossref","first-page":"34250","DOI":"10.1074\/jbc.M704075200","article-title":"p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis","volume":"282","author":"Amaral","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib3","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump (BSEP) promoter is transactivated by the farnesoid X receptor\/bile acid receptor (FXR\/BAR)","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib8","doi-asserted-by":"crossref","first-page":"45139","DOI":"10.1074\/jbc.M405423200","article-title":"Ligand-activated PXR interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha : functional implications in hepatic cholesterol and glucose metabolism","volume":"279","author":"Bhalla","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mce.2022.111618_bib10","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/sj.emboj.7600728","article-title":"Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP","volume":"24","author":"Boulias","year":"2005","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.mce.2022.111618_bib11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to treat metabolic diseases-lessons learned from bariatric surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1006\/mgme.2000.3106","article-title":"Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids [In Process Citation]","volume":"71","author":"Bramlett","year":"2000","journal-title":"Mol. Genet. Metabol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib14","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41467-018-04697-5","article-title":"Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis","volume":"9","author":"Byun","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.mce.2022.111618_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbalip.2019.07.006","article-title":"Ursodeoxycholic acid is a GPBAR1 agonist and resets liver\/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH","volume":"1864","author":"Carino","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","article-title":"Hypothalamic bile acid-TGR5 signaling protects from obesity","volume":"33","author":"Castellanos-Jankiewicz","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111618_bib18","series-title":"A Microbial Metabolite Remodels the Gut-Liver axis Following Bariatric Surgery","author":"Chaudhari","year":"2020"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41589-020-0604-z","article-title":"Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects","volume":"17","author":"Chaudhari","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.gastro.2003.12.013","article-title":"Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity","volume":"126","author":"Chen","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111618_bib22","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.mce.2022.111618_bib24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.12688\/f1000research.12449.1","article-title":"Recent advances in understanding bile acid homeostasis","volume":"6","author":"Chiang","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.mce.2022.111618_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.mce.2022.111618_bib26","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cld.861","article-title":"Bile acid biology, pathophysiology, and therapeutics","volume":"15","author":"Chiang","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.mce.2022.111618_bib28","series-title":"PXR Regulation of Bile Acid Synthesis and Drug Metabolism, DRUG METABOLISM REVIEWS","author":"Chiang","year":"2004"},{"key":"10.1016\/j.mce.2022.111618_bib29","doi-asserted-by":"crossref","first-page":"17502","DOI":"10.1016\/S0021-9258(17)32469-9","article-title":"Identification and characterization of a putative bile acid responsive element in cholesterol 7a-hydroxylase gene promoter","volume":"269","author":"Chiang","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib30","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1074\/jbc.275.15.10918","article-title":"FXR responds to bile acids and represses cholesterol 7a-hydroxylase gene (CYP7A1) transcription","volume":"275","author":"Chiang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib31","first-page":"17","article-title":"Nuclear receptor regulation of the human cholesterol 7a-hydroxylase, sterol 27-hydroxylase and sterol 12a-hydroxylase genes in bile acid synthesis","volume":"120","author":"Chiang","year":"2001","journal-title":"Biol. Bile Acid. Health. Dis."},{"issue":"11","key":"10.1016\/j.mce.2022.111618_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.mce.2022.111618_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025637","article-title":"The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis","volume":"6","author":"Cipriani","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI0214505","article-title":"Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element","volume":"109","author":"Claudel","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"6037","key":"10.1016\/j.mce.2022.111618_bib35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.mce.2022.111618_bib36","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0022-2275(20)39723-6","article-title":"Hormonal regulation of the cholesterol 7 alpha-hydroxylase gene (CYP7)","volume":"36","author":"Crestani","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111618_bib37","first-page":"9","article-title":"The amino acid residues Asn354 and Ile372 of human FXR confer the receptor with high sensitivity to chenodeoxycholate","volume":"9","author":"Cui","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.mce.2022.111618_bib38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/auto.25063","article-title":"Functions of autophagy in normal and diseased liver","volume":"9","author":"Czaja","year":"2013","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0022-2275(20)31482-6","article-title":"Regulation of cholesterol-7alpha-hydroxylase. Barely missing a shp","volume":"43","author":"Davis","year":"2002","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib40","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/hep.29325","article-title":"Hepatic bile acid uptake in humans and mice: multiple pathways and expanding potential role for gut-liver signaling","volume":"66","author":"Dawson","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib41","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M103270200","volume":"276","author":"De Fabiani","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.mce.2022.111618_bib42","doi-asserted-by":"crossref","first-page":"17793","DOI":"10.1074\/jbc.M000996200","article-title":"a1-fetoprotein transcription factor is required for the expression of sterol 12a-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription","volume":"275","author":"del Castillo-Olivares","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"issue":"7405","key":"10.1016\/j.mce.2022.111618_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.28689","article-title":"Vertical sleeve gastrectomy activates GPBAR-1\/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice","volume":"64","author":"Ding","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","article-title":"Production rates in normal human subjects","volume":"40","author":"Duane","year":"1999","journal-title":"J. Lipid Res."},{"issue":"33","key":"10.1016\/j.mce.2022.111618_bib47","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M501931200","article-title":"The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition","volume":"280","author":"Duran-Sandoval","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","article-title":"Novel therapeutic targets in primary biliary cirrhosis","volume":"12","author":"Dyson","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1515\/hsz-2018-0379","article-title":"Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1","volume":"400","author":"Fan","year":"2019","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"issue":"2 Suppl. 1","key":"10.1016\/j.mce.2022.111618_bib51","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.mce.2022.111618_bib52","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1194\/jlr.R900009-JLR200","article-title":"Bile acids: role of peroxisomes","volume":"50","author":"Ferdinandusse","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111618_bib53","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.M064709","article-title":"Cholesterol 7{alpha}-hydroxylase-deficient mice are protected from high fat\/high cholesterol diet-induced metabolic disorders","volume":"57","author":"Ferrell","year":"2016","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib54","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.30513","article-title":"Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice","volume":"70","author":"Ferrell","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib56","doi-asserted-by":"crossref","first-page":"G412","DOI":"10.1152\/ajpgi.00300.2018","article-title":"Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice","volume":"316","author":"Finn","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"11","key":"10.1016\/j.mce.2022.111618_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract","volume":"15","author":"Foley","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mce.2022.111618_bib59","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/cld.1143","article-title":"Statins show promise against progression of liver disease","volume":"18","author":"Francis","year":"2021","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib61","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib62","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib63","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.mce.2022.111618_bib64","series-title":"Current Status and Clinical Applications","author":"Gege","year":"2019"},{"key":"10.1016\/j.mce.2022.111618_bib65","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor Axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell."},{"issue":"572","key":"10.1016\/j.mce.2022.111618_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib69","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.mce.2022.111618_bib70","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1074\/jbc.M010878200","article-title":"Down-regulation of cholesterol 7alpha -hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-jun N-terminal kinase pathway","volume":"276","author":"Gupta","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.ATV.0000195793.73118.b4","article-title":"Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4","volume":"26","author":"Gutierrez","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.mce.2022.111618_bib72","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib73","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-\/- mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"issue":"40","key":"10.1016\/j.mce.2022.111618_bib74","doi-asserted-by":"crossref","first-page":"36869","DOI":"10.1074\/jbc.R100029200","article-title":"The multifaceted mechanisms of estradiol and estrogen receptor signaling","volume":"276","author":"Hall","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib76","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.30590","article-title":"NGM282 improves liver fibrosis and histology in 12 Weeks in patients with nonalcoholic steatohepatitis","volume":"71","author":"Harrison","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J. Hepatol."},{"issue":"24","key":"10.1016\/j.mce.2022.111618_bib79","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1021\/jm501052c","article-title":"G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype","volume":"57","author":"Hogenauer","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib80","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1194\/jlr.D600032-JLR200","article-title":"Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS\/MS","volume":"48","author":"Honda","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111618_bib81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.31265","article-title":"FXR agonists as therapy for liver disease","volume":"72","author":"Hoofnagle","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib83","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/me.2007-0113","article-title":"In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue","volume":"21","author":"Houten","year":"2007","journal-title":"Mol. Endocrinol."},{"issue":"5771","key":"10.1016\/j.mce.2022.111618_bib84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","article-title":"Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration","volume":"312","author":"Huang","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hepr.13001","article-title":"Reciprocal interactions between bile acids and gut microbiota in human liver diseases","volume":"48","author":"Ikegami","year":"2018","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metabol."},{"issue":"10","key":"10.1016\/j.mce.2022.111618_bib87","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib88","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","article-title":"Bile acid is a host factor that regulates the composition of the cecal microbiota in rats","volume":"141","author":"Islam","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111618_bib89","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.00207.2004","article-title":"Cytokine regulation of human sterol 12{alpha}-hydroxylase (CYP8B1) gene","volume":"288","author":"Jahan","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib90","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib91","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib92","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111618_bib93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4614-0887-1_11","article-title":"Physiology of FGF15\/19","volume":"728","author":"Jones","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mce.2022.111618_bib94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2019.01.011","article-title":"Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols","volume":"189","author":"Kakiyama","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib95","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cmet.2015.05.004","article-title":"Detection of FGF15 in plasma by stable isotope standards and capture by anti-peptide antibodies and targeted mass spectrometry","volume":"21","author":"Katafuchi","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111618_bib96","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib97","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"45","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib98","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2022.111618_bib99","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1534-5807(02)00154-5","article-title":"Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis","volume":"2","author":"Kerr","year":"2002","journal-title":"Dev. Cell"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib101","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mce.2022.111618_bib102","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J. Lipid Res."},{"issue":"6024","key":"10.1016\/j.mce.2022.111618_bib103","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2020.07.028","article-title":"Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis","volume":"74","author":"Kjaergaard","year":"2021","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib106","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib107","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib108","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1992.tb05139.x","article-title":"Evolution of the nuclear receptor gene superfamily","volume":"11","author":"Laudet","year":"1992","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib109","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MCB.20.1.187-195.2000","article-title":"The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression","volume":"20","author":"Lee","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"7529","key":"10.1016\/j.mce.2022.111618_bib110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature13961","article-title":"Nutrient-sensing nuclear receptors coordinate autophagy","volume":"516","author":"Lee","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib111","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hep.27804","article-title":"Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice","volume":"62","author":"Lee","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib112","doi-asserted-by":"crossref","first-page":"G74","DOI":"10.1152\/ajpgi.00258.2004","article-title":"Mechanism of rifampicin and pregnane X receptor (PXR) inhibition of human cholesterol 7{alpha}-hydroxylase gene (CYP7A1) transcription","volume":"288","author":"Li","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib113","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib114","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.21183","article-title":"Bile acids and cytokines inhibit the human cholesterol 7alpha-hydroxylase gene via the JNK\/c-jun pathway in human liver cells","volume":"43","author":"Li","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib116","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2010-0460","article-title":"The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling","volume":"25","author":"Li","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib117","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1074\/jbc.M111.305789","article-title":"Glucose and insulin induction of bile acid synthesis: mechanisms and implication IN diabetes and obesity","volume":"287","author":"Li","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib118","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib119","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","article-title":"Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15\/19 signaling to repress bile acid synthesis","volume":"20","author":"Li","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111618_bib120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth via activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.31622","article-title":"Combination therapies including cilofexor and Firsocostat for bridging fibrosis and cirrhosis attributable to NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093567","article-title":"GPBAR1\/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib123","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol. Cell."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib124","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111618_bib125","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mce.2022.111618_bib126","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib127","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101397R","article-title":"Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling","volume":"36","author":"Marchiano","year":"2022","journal-title":"Faseb. J."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4 Pt 2 Suppl. l","key":"10.1016\/j.mce.2022.111618_bib129","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510280422","article-title":"Cholesterol 7alpha-hydroxylase (CYP7A): patterns of messenger RNA expression during rat liver development [In Process Citation]","volume":"28","author":"Massimi","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2015-309871","article-title":"TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice","volume":"66","author":"McGavigan","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.mce.2022.111618_bib131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2017.00191","article-title":"Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice","volume":"11","author":"McMillin","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.mce.2022.111618_bib132","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.M510713200","article-title":"Functional inhibitory cross-talk between car and HNF-4 in hepatic lipid\/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha","volume":"281","author":"Miao","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib133","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/me.2011-0033","article-title":"Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes","volume":"25","author":"Miao","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"29","key":"10.1016\/j.mce.2022.111618_bib134","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib135","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1194\/jlr.M087239","article-title":"Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation","volume":"59","author":"Miyazaki-Anzai","year":"2018","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib136","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11938-020-00290-2","article-title":"An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment","volume":"18","author":"Mouzaki","year":"2020","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib138","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid x receptor agonist obeticholic Acid in patients with type 2 diabetes and nonalcoholic Fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib139","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib141","doi-asserted-by":"crossref","first-page":"154844","DOI":"10.1016\/j.metabol.2021.154844","article-title":"Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease","volume":"123","author":"Nawrot","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2022.111618_bib142","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-018-3216-x","article-title":"Increased bile acids and FGF19 after sleeve gastrectomy and roux-en-Y gastric bypass correlate with improvement in type 2 diabetes in a randomized trial","author":"Nemati","year":"2018","journal-title":"Obes. Surg."},{"issue":"9972","key":"10.1016\/j.mce.2022.111618_bib143","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib144","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib146","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0016-5085(95)90083-7","article-title":"Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas","volume":"108","author":"Pandak","year":"1995","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib147","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.22196","article-title":"Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis","volume":"47","author":"Park","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib148","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.mce.2022.111618_bib149","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1074\/jbc.M117.784322","article-title":"Farnesoid X receptor induces Takeda G-protein receptor 5 crosstalk to regulate bile acid synthesis and hepatic metabolism","volume":"292","author":"Pathak","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111618_bib150","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib151","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.26463","article-title":"The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice","volume":"58","author":"Pean","year":"2013","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.mce.2022.111618_bib152","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.mce.2022.111618_bib153","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI76289","article-title":"TGR5 reduces macrophage migration through mTOR-induced C\/EBPbeta differential translation","volume":"124","author":"Perino","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib154","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine","volume":"26","author":"Potthoff","year":"2012","journal-title":"Gene Dev."},{"issue":"Suppl. 1","key":"10.1016\/j.mce.2022.111618_bib156","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.mce.2022.111618_bib157","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2011-2145","article-title":"The role of bile after roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control","volume":"153","author":"Pournaras","year":"2012","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib158","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib159","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111618_bib160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111618_bib161","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/S0022-2275(20)30029-8","article-title":"Activation of protein kinase Ca and d by bile acids: correlation with bile acid structure and diacylglycerol formation","volume":"38","author":"Rao","year":"1997","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib162","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib163","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib164","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbadis.2010.01.002","article-title":"The bile acid sensor FXR regulates insulin transcription and secretion","author":"Renga","year":"2010","journal-title":"Biochim. Biophys. Acta."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microb."},{"issue":"9","key":"10.1016\/j.mce.2022.111618_bib166","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.soard.2017.05.024","article-title":"Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial","volume":"13","author":"Risstad","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.mce.2022.111618_bib167","doi-asserted-by":"crossref","first-page":"1370174","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1888673","article-title":"Links between gut microbiome composition and fatty liver disease in a large population sample","volume":"13","author":"Ruuskanen","year":"2021","journal-title":"Gut Microb."},{"key":"10.1016\/j.mce.2022.111618_bib169","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature13135","article-title":"FXR is a molecular target for the effects of vertical sleeve gastrectomy","volume":"509","author":"Ryan","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metabol."},{"issue":"7529","key":"10.1016\/j.mce.2022.111618_bib171","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13949","article-title":"Transcriptional regulation of autophagy by an FXR-CREB axis","volume":"516","author":"Seok","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mce.2022.111618_bib172","doi-asserted-by":"crossref","first-page":"609060","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.mce.2022.111618_bib173","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s11695-012-0673-5","article-title":"Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass","volume":"22","author":"Simonen","year":"2012","journal-title":"Obes. Surg."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib174","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"issue":"7242","key":"10.1016\/j.mce.2022.111618_bib175","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.mce.2022.111618_bib176","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-2275(20)40050-1","article-title":"Developmental expression of elements of hepatic cholesterol metabolism in the rat","volume":"36","author":"Smith","year":"1995","journal-title":"J. Lipid Res."},{"issue":"25","key":"10.1016\/j.mce.2022.111618_bib177","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2174\/092986706778521823","article-title":"Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors","volume":"13","author":"Sola","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib178","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.21878","article-title":"Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes","volume":"46","author":"Song","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib179","first-page":"275","article-title":"Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis","volume":"2","author":"Song","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib181","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Srivastava","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"2 Pt 1","key":"10.1016\/j.mce.2022.111618_bib182","first-page":"G508","article-title":"Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A","volume":"273","author":"Stroup","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib183","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mce.2022.111618_bib184","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.mce.2022.111618_bib186","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.mce.2022.111618_bib187","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib188","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib189","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23450","article-title":"Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine","volume":"51","author":"Thomas","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib190","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.mce.2022.111618_bib191","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2022.111618_bib192","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib193","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib194","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1534-5807(02)00187-9","article-title":"Redundant pathways for negative feedback regulation of bile Acid production","volume":"2","author":"Wang","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2005.08.010","article-title":"The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metabol."},{"issue":"7","key":"10.1016\/j.mce.2022.111618_bib196","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/me.2007-0527","article-title":"Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo","volume":"22","author":"Wang","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib197","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmgh.2016.10.002","article-title":"Targeting the enterohepatic bile acid signaling induces hepatic autophagy via a CYP7A1-AKT-mTOR Axis in mice","volume":"3","author":"Wang","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib198","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.mce.2022.111618_bib199","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mce.2022.111618_bib201","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An intestinal farnesoid X receptor-ceramide signaling Axis modulates hepatic gluconeogenesis in mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib202","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jcmgh.2020.10.011","article-title":"Hepatic autophagy deficiency remodels gut microbiota for adaptive protection via FGF15-FGFR4 signaling","volume":"11","author":"Yan","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib204","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/mi.2016.42","article-title":"Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice","volume":"10","author":"Yang","year":"2017","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/imm.12045","article-title":"TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease","volume":"139","author":"Yoneno","year":"2013","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2022.111618_bib207","doi-asserted-by":"crossref","first-page":"41690","DOI":"10.1074\/jbc.M105117200","article-title":"Transcriptional regulation of the human sterol 12a-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4a (HNF4a) in mediating bile acid repression","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mce.2022.111618_bib208","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib209","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1074\/jbc.M109.083899","article-title":"Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mce.2022.111618_bib210","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/MCB.01076-09","article-title":"Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth","volume":"30","author":"Zhang","year":"2010","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.mce.2022.111618_bib211","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00070-16","article-title":"Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism","volume":"1","author":"Zhang","year":"2016","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.mce.2022.111618_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"10.1016\/j.mce.2022.111618_bib213","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072200065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072200065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:21:40Z","timestamp":1759587700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030372072200065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":213,"alternative-id":["S030372072200065X"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2022.111618","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of farnesoid X receptor and its role in bile acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2022.111618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111618"}}